Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma

Ruichao Chen^1*, Minfeng Zhang^1*, Qiulian Li^1,5*, Hanzhen Xiong¹, Shaoyan Liu¹, Weiyi Fang³, Qianbing Zhang³, Zhen Liu^1,2✉, Xuehu Xu^4✉, Qingping Jiang^1✉

1. Department of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, PR, China;
2. Department of Pathology, Basic school, Guangzhou Medical University, Guangzhou,510000, PR China;
3. Cancer Research Institute, Southern Medical University, Guangzhou, 510515, PR China;
4. Gastrointestinal Department, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510150, PR, China;
5. Department of obstetrics and gynecology, First affiliated hospital, Gannan medical university, Gannan,341000, PR, China.
^*These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.

Citation:
Chen R, Zhang M, Li Q, Xiong H, Liu S, Fang W, Zhang Q, Liu Z, Xu X, Jiang Q. Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J Cancer 2017; 8(16):3130. doi:10.7150/jca.22507. Available from https://www.jcancer.org/v08p3130.htm

Retracted-article in J Cancer, Volume 8, 305